Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00801151
Recruitment Status : Terminated
First Posted : December 3, 2008
Last Update Posted : May 20, 2010
Merck Sharp & Dohme Corp.
Information provided by:
Institut Claudius Regaud

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 2009
  Actual Study Completion Date : November 2009